Results 221 to 230 of about 2,436,024 (405)

Retraction: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma

Pathology and Oncology Research
Pathology and Oncology Research Editorial Office
doaj   +1 more source

An analysis of palliative care in adolescents and young adults with soft tissue and bone sarcomas. [PDF]

Palliat Care Soc Pract
Wytiaz V, Marks A, Mayers A, Shami S, Schuetze S, Chugh R.   +5 more
europepmc   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Correction: Laparoscopic Versus Robotic Adrenalectomy: A Randomized Clinical Trial. [PDF]

Ann Surg Oncol
Berber E, Ibrahimli A, Memisoglu E, Akgun E, Perez-Soto R.   +4 more
europepmc   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Metachronous Pheochromocytoma and Cholangiocarcinoma in a patient with Neurofibromatosis type 1: a case report. [PDF]

Oxf Med Case Reports
Al Harrak Y, Lkhoyaali S, Lamsyah O, Boutayeb S, El Ghissassi I, M'rabti H, Errihani H.   +6 more
europepmc   +1 more source

Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up

, 2009
Peter H. Wiernik, Fangxin Hong, John H. Glick, John M. Bennett   +3 more
openalex   +2 more sources

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients. [PDF]

Signal Transduct Target Ther
Yang Y, Wu Y, Zhao J, Zhang T, Fei K, Zhao X, Deng L, Zhang Z, Jiang Y, Wang J, Liu W, Wang X, Wang S, Bao H, Wu X, Zhu M, Ou Q, Tang W, Wang L, Wang Z, Bi N.   +20 more
europepmc   +1 more source

Positron-emission tomography/computed tomography imaging in head and neck oncology: An update

, 2016
Viet D. Nguyen, Bundhit Tantiwongkosi, Wyatt J Weinheimer, Frank R. Miller   +3 more
openalex   +1 more source